Zobrazeno 1 - 10
of 285
pro vyhledávání: '"Yukiyasu, Ozawa"'
Autor:
Shohei Mizuno, Akiyoshi Takami, Koji Kawamura, Kaito Harada, Masuko Masayoshi, Shingo Yano, Ayumu Ito, Yukiyasu Ozawa, Fumihiko Ouchi, Takashi Ashida, Yuichiro Nawa, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Atsuta, Masamitsu Yanada
Publikováno v:
eJHaem, Vol 5, Iss 2, Pp 369-378 (2024)
Abstract BCR::ABL1 fusion is found in
Externí odkaz:
https://doaj.org/article/a4f3734c09f64c24bc3a62ed96037de3
Autor:
Tomoyasu Jo, Yasuyuki Arai, Junya Kanda, Tadakazu Kondo, Kazuhiro Ikegame, Naoyuki Uchida, Noriko Doki, Takahiro Fukuda, Yukiyasu Ozawa, Masatsugu Tanaka, Takahide Ara, Takuro Kuriyama, Yuta Katayama, Toshiro Kawakita, Yoshinobu Kanda, Makoto Onizuka, Tatsuo Ichinohe, Yoshiko Atsuta, Seitaro Terakura
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-11 (2023)
Abstract Background Forecasting acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) is highly challenging with conventional statistical techniques due to complex parameters and their interactions. T
Externí odkaz:
https://doaj.org/article/7d45f5c179554d47a86525b9d7124fdc
Autor:
Masaharu Tamaki, Yu Akahoshi, Masahiro Ashizawa, Yukiko Misaki, Satoshi Koi, Sung-Won Kim, Yukiyasu Ozawa, Shin-ichiro Fujiwara, Shinichi Kako, Ken-ichi Matsuoka, Masashi Sawa, Yuta Katayama, Makoto Onizuka, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Kimikazu Yakushijin, Hideki Nakasone
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Allogeneic hematopoietic cell transplantation between female donors and male recipients (female-to-male allo-HCT) is a well-established risk factor for inferior survival outcomes due to a higher incidence of graft-versus-host disease (GVHD).
Externí odkaz:
https://doaj.org/article/854cda6ed879453093573fa734c2550c
Autor:
Nobuaki Nakano, Hideki Nakasone, Shigeo Fuji, Akihito Shinohara, Ritsuro Suzuki, Atae Utsunomiya, Tetsuya Eto, Satoko Morishima, Kazuhiro Ikegame, Yasutaka Kakinoki, Ken-ichi Matsuoka, Yasuo Mori, Youko Suehiro, Naoyuki Uchida, Ayumu Ito, Noriko Doki, Yukiyasu Ozawa, Junya Kanda, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Masao Ogata
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 40, Iss , Pp 100902- (2023)
Summary: Background: Human T-cell leukemia virus type I (HTLV-1) is a retrovirus known to cause adult T-cell leukemia/lymphoma (ATL). There are few reports on hematopoietic stem cell transplantation (HSCT) for d HTLV-1 carriers with diseases other th
Externí odkaz:
https://doaj.org/article/a79f543a74c44bd68df2297e75f9834a
Autor:
Hiroki Mizumaki, Ken Ishiyama, Jun Aoki, Jinichi Mori, Shohei Mizuno, Noriko Doki, Takahiro Fukuda, Naoyuki Uchida, Masahito Onizuka, Masatsugu Tanaka, Yuta Katayama, Yukiyasu Ozawa, Kazuhiro Ikegame, Satoru Takada, Toshiro Kawakita, Nobuyuki Aotsuka, Yoshiko Atsuta, Masamitsu Yanada
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 251-257 (2023)
Abstract The prognosis of acute myeloid leukemia (AML) patients with der(1;7)(q10;p10) who underwent allogeneic hematopoietic stem cell transplantation (allo‐SCT) is unclear due to its rarity. We retrospectively analyzed 151 AML patients with der(1
Externí odkaz:
https://doaj.org/article/f8c29b89765d4b6d9344c3c0455cf547
Autor:
Yukiko Misaki, Masaharu Tamaki, Ryu Yanagisawa, Noriko Doki, Takahiro Fukuda, Naoyuki Uchida, Masatsugu Tanaka, Yukiyasu Ozawa, Masashi Sawa, Takahide Ara, Junya Kanda, Yoshiko Atsuta, Yoshinobu Kanda, Hideki Nakasone
Publikováno v:
HemaSphere, Vol 7, p e5442011 (2023)
Externí odkaz:
https://doaj.org/article/34ba38e12ffb44ab8dfa6607774040c8
Autor:
Shigeo Fuji, Akitoshi Hakoda, Junya Kanda, Takahiro Fukuda, Noriko Doki, Yuta Katayama, Naoyuki Uchida, Yukiyasu Ozawa, Yoshinobu Kanda, Masatsugu Tanaka, Keisuke Kataoka, Takahide Ara, Masashi Sawa, Makoto Onizuka, Yasushi Onishi, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Ayumi Shintani, Satoko Morishima
Publikováno v:
HemaSphere, Vol 7, p e0799573 (2023)
Externí odkaz:
https://doaj.org/article/ca7d6ed0ed1d4941ac0d6d84354031ca
Autor:
Takaaki Konuma, Shohei Mizuno, Tadakazu Kondo, Yasuyuki Arai, Naoyuki Uchida, Satoshi Takahashi, Masatsugu Tanaka, Takuro Kuriyama, Shigesaburo Miyakoshi, Makoto Onizuka, Shuichi Ota, Yasuhiro Sugio, Yasushi Kouzai, Toshiro Kawakita, Hikaru Kobayashi, Yukiyasu Ozawa, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Masamitsu Yanada, for the Adult Acute Myeloid Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 5, Pp 1-12 (2022)
Abstract Unrelated cord blood transplantation (CBT) is an alternative curative option for adult patients with acute myeloid leukemia (AML) who need allogeneic hematopoietic cell transplantation (HCT) but lack an HLA-matched related or unrelated donor
Externí odkaz:
https://doaj.org/article/660bfbb942e140e3b2a59f19b7d5883d
Autor:
Naomi Kawashima, Yuichi Ishikawa, Jeong Hui Kim, Yoko Ushijima, Akimi Akashi, Yohei Yamaguchi, Hikaru Hattori, Marie Nakashima, Seara Ikeno, Rika Kihara, Takahiro Nishiyama, Takanobu Morishita, Koichi Watamoto, Yukiyasu Ozawa, Kunio Kitamura, Hitoshi Kiyoi
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
Clonal dynamics and selection have not been fully understood in patient-derived xenografts (PDX) of acute myeloid leukemia (AML). Here, the authors generate 160 AML-PDX models to track the clonal dynamics of primary and relapsed AML, and find selecti
Externí odkaz:
https://doaj.org/article/5a01dd325554447594f018972aa0e952
Autor:
Shuhei Kurosawa, Shohei Mizuno, Yasuyuki Arai, Masayoshi Masuko, Junya Kanda, Kentaro Kohno, Daishi Onai, Takahiro Fukuda, Yukiyasu Ozawa, Yuta Katayama, Masatsugu Tanaka, Kazuhiro Ikegame, Naoyuki Uchida, Tetsuya Eto, Shuichi Ota, Junji Tanaka, Tatsuo Ichinohe, Yoshiko Atsuta, Masamitsu Yanada
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 9, Pp 1-8 (2021)
Abstract The present study evaluated outcomes and prognostic factors in adult patients with acute myeloid leukemia (AML) after syngeneic hematopoietic stem cell transplantation (HSCT). Among patients in first complete remission (CR1), outcomes of syn
Externí odkaz:
https://doaj.org/article/4536ccadd7614397adced0e486e49c49